Bibliography:
[1] Guidelines for the prevention and treatment of hypertension in China (2018 revised edition)[J]. Chinese Journal of Cardiovascular,2019,24(01):24-56.
[2] Cardiovascular Disease Branch of Chinese Society of Gerontology and Geriatrics, Chinese Hypertension Alliance. Recommendations for the clinical application of β receptor blockers in the treatment of hypertension [J]. Chinese Journal of Cardiovascular Diseases, 2019, 47(6): 443-446.
[3] Guideline for the pharmacological treatment of hypertension in adults [Internet]. Geneva: World Health Organization; 2021.
[4] Jones NR, McCormack T, Constanti M, McManus RJ. Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract. 2020 Jan 30; 70(691):90-91.
[5] Hypertension Branch of Chinese Geriatrics Society, Beijing Association for Prevention and Treatment of Hypertension, National Clinical Research Center for Geriatric Diseases (General Hospital of Chinese People's Liberation Army, Xuanwu Hospital of Capital Medical University), et al. Guidelines for the management of hypertension in the elderly in China 2023[J]. Chinese Journal of Hypertension,2023,31(06):508-538.
[6] Chinese Medical Association, Chinese Society of Clinical Pharmacy, Chinese Medical Association
This article is transferred from: Lilac Garden Cardiovascular Time